Walgreens Boots Alliance has enlisted advisers Perella Weinberg Partners and AlixPartners to assist with operations and balance sheet of the company as the company continues to face financial pressures, Bloomberg reported Feb. 12.
In an era of rapid healthcare transformation, two health systems are making important pharmacy investments to enhance operational efficiency, improve patient care and navigate the financial pressures going into 2025.
Amid ongoing healthcare workforce shortages, some leading hospitals and health systems are adopting creative strategies to recruit and retain pharmacy technicians.
The American Society of Health-System Pharmacists has named the recipients of its 2025 Board of Directors awards, which the organization will present during its national meetings.
A phase 3 trial found that a combination of a Pfizer and Astellas drug, enfortumab vedotin, and Merck's drug, pembrolizumab, has significantly improved survival rates for patients with advanced bladder cancer.
Bristol Myers Squibb will cut $2 billion in costs by the end of 2027, a move aimed at long-term growth as the company prepares for patent expirations on key treatments, CNBC reported Feb. 6.